Pharmaceutical Technology - May 2019

Pharmaceutical Technology - eBook

Issue link: https://www.e-digitaleditions.com/i/1118782

Contents of this Issue

Navigation

Page 35 of 50

36 Pharmaceutical Technology BIOLOGICS AND STERILE DRUG MANUFACTURING 2019 P h a r mTe c h . c o m Supply Chain T he implementation of single-use systems (SUS) for bio- pharmaceutical manufacturing as an alternative to or in combination with traditional stainless-steel equipment offers advantages such as reduced capital cost, faster facil- ity construction, and more f lexible and efficient manufacturing (1). In a fully disposable or hybrid facility, however, because pieces of equipment (e.g., reactors, transfer tubing, holding vessels) are now consumables, the supply to the manufacturing facility is more com- plex. The demand for customized systems and the overall growth of demand for SUS add to the pressure to improve supply. Most SUS are currently made in the United States and the Eu- ropean Union, but suppliers are exploring manufacturing of SUS components in Asia to serve the region's growing biopharma market more efficiently. In September 2018, MilliporeSigma announced its first Mobius single-use manufacturing facility in Wuxi, China would begin production in 2019 (2), and in November 2018, GE Healthcare announced a collaboration with Chinese healthcare technology supplier Wego Pharmaceutical to produce single-use consumables in Weihai, China using GE's Fortem platform film (3). Shorter lead times are one potential benefit. Local production could also reduce the environmental impact of shipping components over long distances (4). Pharmaceutical Technology spoke with Andrew Bulpin, head of Process Solutions at MilliporeSigma; Jeff Carter, strategic project leader at GE Healthcare Life Sciences; Eric Isberg, director of Life Sciences at Entegris; and Helene Pora, vice-president of Technical Communication and Regulatory Strategy at Pall about some of the issues facing the industry as companies look to SUS for biopharma- ceutical manufacturing. Supply Chain Challenges for Single-Use Systems Jennifer Markarian Suppliers address the complexity of supplying disposable components to the global biopharmaceutical manufacturing industry. KRUNJA - STOCK.ADOBE.COM

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - May 2019 - Pharmaceutical Technology - eBook